Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Frankfurt - Delayed Quote • EUR Avantor, Inc. (AVG.F) Follow Add holdings 11.20 +0.10 +(0.90%) At close: 8:18:42 AM GMT+2 All News Press Releases SEC Filings Avantor® to Participate in Bank of America Securities 2025 Health Care Conference Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that Michael Stubblefield, President and CEO, will be participating in a fireside chat at the Bank of America Securities 2025 Health Care Conference in Las Vegas on Tuesday, May 13, 2025 at approximately 10:00 a.m. Pacific Time. Avantor, Inc. (AVTR): Among the Oversold Global Stocks to Buy According to Hedge Funds We recently published a list of 11 Oversold Global Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Avantor, Inc. (NYSE:AVTR) stands against other oversold global stocks to buy according to hedge funds. Global stocks are businesses that have a diversified revenue base and do not […] Why Avantor, Inc. (AVTR) Crashed on Monday We recently published an article titled Traders Heavily Dumped These 10 Firms on Monday. In this article, we are going to take a look at where Avantor, Inc. (NYSE:AVTR) stands against the other stocks. A lackluster trading persisted on the stock market on Monday, with Wall Street’s major indices finishing mixed, as investors continued to digest and […] Analysts downgrade Avantor on earnings miss, CEO transition and tariff risks Investing.com -- Wall Street turned bearish on Avantor (NYSE:AVTR) with Stifel and Morgan Stanley downgraded the stock to "Neutral" and "Equal-weight," respectively driven by a disappointing first-quarter performance, management changes, and emerging tariff risks. Avantor Stock Declines Despite Q1 Earnings In-Line, Revenues Down Y/Y AVTR's Bioscience Production segment witnesses robust growth amid macroeconomic pressures. 3 Hated Stocks in the Doghouse Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a company faces serious headwinds. China weighs U.S. tariff exemptions, Alphabet reports Q1 beat: Morning Buzz The major averages were mixed near noon following several days of gains as investors process the latest batch of earnings reports, including a notable one from a big tech bellwether. Optimism over easing U.S.-China trade tensions, particularly with China reportedly considering tariff exemptions for certain American products, is also being weighed, though President Trump said he would consider it a “total victory” if the U.S. has high tariffs of 20%-50% on foreign nations a year from now, accordi Avantor Inc (AVTR) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... Despite a 2% organic revenue decline, Avantor Inc (AVTR) focuses on digital enhancements and cost-saving measures to drive future growth. Q1 2025 Avantor Inc Earnings Call Q1 2025 Avantor Inc Earnings Call Why Avantor (AVTR) Shares Are Falling Today Shares of life sciences company Avantor (NYSE:AVTR) fell 21.2% in the afternoon session after the company reported a weak first-quarter 2025 performance, as its organic revenue and total sales both missed Wall Street's expectations. Sales dropped 6% from a year ago, reflecting softness across both major business segments. Lab Solutions declined 8% while Bioscience Production slipped slightly. Encouragingly, management raised its cost savings target to $400 million by 2027 and signaled urgency to Avantor Stock Plummets as Firm's CEO Set to Leave Amid Sales Slump, Outlook Cut Avantor's CEO is stepping down after 11 years as head of the chemical and other life sciences company. Compared to Estimates, Avantor (AVTR) Q1 Earnings: A Look at Key Metrics While the top- and bottom-line numbers for Avantor (AVTR) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. Avantor, Inc. (AVTR) Q1 Earnings Meet Estimates Avantor (AVTR) delivered earnings and revenue surprises of 0% and 1.72%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock? Avantor (NYSE:AVTR) Misses Q1 Revenue Estimates Life sciences company Avantor (NYSE:AVTR) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 5.9% year on year to $1.58 billion. Its non-GAAP profit of $0.23 per share was in line with analysts’ consensus estimates. Avantor® Announces CEO Transition Avantor, Inc., a leading global provider of mission-critical products and services for the life sciences and advanced technology industries, today announced that Michael Stubblefield intends to step down from his role as Director, President and Chief Executive Officer upon the appointment of a successor. Avantor® Reports First Quarter 2025 Results Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today reported financial results for its first fiscal quarter ended March 31, 2025. Avantor (NYSE:AVTR) investors are sitting on a loss of 47% if they invested three years ago As an investor its worth striving to ensure your overall portfolio beats the market average. But if you try your hand... Earnings To Watch: Avantor (AVTR) Reports Q1 Results Tomorrow Life sciences company Avantor (NYSE:AVTR) will be reporting earnings tomorrow before market open. Here’s what you need to know. Danaher (DHR) Surpasses Q1 Earnings and Revenue Estimates Danaher (DHR) delivered earnings and revenue surprises of 16.05% and 3.34%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock? Reflecting On Research Tools & Consumables Stocks’ Q4 Earnings: Agilent (NYSE:A) Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Agilent (NYSE:A) and its peers. Performance Overview Trailing total returns as of 5/2/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) Return AVG.F S&P 500 (^GSPC) YTD -44.00% -3.31% 1-Year -50.00% +12.29% 3-Year -62.38% +36.85%